Skip to main content
Market intelligence
TLSIHealthcare

TriSalus Life Sciences Inc insider activity

In the last 90 days, 5 corporate insiders purchased $1,821,429 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$1,821,429
Corporate buyers
5
Latest transaction
May 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 15, 2026Richard MarshakChief Commercial OfficerSale543$2.67$1,450
May 15, 2026Mats WahlstromCorporate insiderOpen Market Purchase60,000$2.53$151,800
May 15, 2026Michael P StanskyCorporate insiderOpen Market Purchase610,000$2.50$1,525,000